Pfizer COVID-19 Pill

• COVID-19 pill will be available to thousands in Britain in February

  Britain's health ministry said that Pfizer's antiviral treatment Paxlovid will be made available to thousands of people beginning Feb. 10.

  World

  Jan 28, 2022
  
• COVID-19 pills in low supply in U.S. due to months-long manufacturing time

  The problem, in part, is that production is still being ramped up and the medicines can take anywhere from five to eight months to manufacture.

  World

  Jan 14, 2022
  
• Advertisement
• Newly approved COVID-19 pills come with a catch. Here’s what you should know

  U.S. regulators authorized Pfizer's pill, Paxlovid, and Merck's molnupiravir this week.

  Health

  Dec 26, 2021
• Advertisement
• Pfizer’s COVID-19 pill appears effective against Omicron variant, company says

  The Canadian government announced earlier this month it has reached an agreement with Pfizer for one million courses of its treatment, pending Health Canada approval.

  Health

  Dec 14, 2021
• Canada secures orders of Merck, Pfizer COVID-19 antiviral pills

  Canada has announced it has signed purchasing agreements with Pfizer and Merck for their COVID-19 antiviral pills designed to treat the virus.

  Health

  Dec 3, 2021
• Pfizer begins approval process for COVID-19 antiviral pill in Canada

  Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.

  Canada

  Dec 1, 2021
• Pfizer files for U.S. authorization of its pill to treat COVID-19

  Pfizer says that its COVID-19 treatment pill can help to significantly cut the risk of death or hospitalization in high-risk adults.

  Health

  Nov 16, 2021
• Pfizer to allow other companies to make its COVID-19 pill

  COVID-19 vaccine maker Pfizer has agreed to grant a license for its antiviral pill to the Medicines Patent Pool, which would allow other companies to make the treatment.

  Health

  Nov 16, 2021
• Advertisement
• New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says

  Pfizer's pill to treat COVID-19 reduces the risk of hospitalization and death by nearly 90 per cent, the company said Friday when it released preliminary results.

  Health

  Nov 5, 2021